Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300519 stock hub

SHE/300519 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300519is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.7B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300519

In the news

Latest news · SHE/300519

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E47.4

P25 23.5P50 41.3P75 83.2

ROE6.5

P25 -0.9P50 4.1P75 8.8

ROIC31.5

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300519 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

CNY

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	316
Employees Change	1%
Employees Change Percent	0.32
Enterprise value	CNY 1.9B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000027T3
Last refreshed	2026-05-10
Market cap	CNY 2.7B
Price	CNY 16.62
Price currency	CNY
Rev Per Employee	824,617.27x
Sector	Healthcare
Sic	2834
Symbol	she/300519
Website	https://www.xgpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.11%
EV Earnings	33.69x
EV/EBIT	33.77x
EV/EBITDA	26.74x
EV/FCF	24.77x
EV/Sales	7.24x
FCF yield	2.87%
P/B ratio	3.08x
P/E ratio	47.38x
P/S ratio	10.2x
PE Ratio10 Y	33.43x
PE Ratio3 Y	38.97x
PE Ratio5 Y	33.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.45%
EBITDA Margin	27.09%
FCF margin	29.25%
Gross margin	41.46%
Gross Profit	CNY 108M
Gross Profit Growth	13.6%
Gross Profit Growth Q	16.98%
Gross Profit Growth3 Y	-17.27%
Gross Profit Growth5 Y	-7.8%
Net Income	CNY 56M
Net Income Growth	7.58%
Net Income Growth Q	7.44%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	-20.73%
Net Income Growth5 Y	-11.34%
Pretax Margin	25.23%
Profit Margin	21.51%
Profit Per Employee	CNY 177,334
Profitable Years	15
ROA	3.79
Roa5y	4.71
ROCE	6.41
ROE	6.52
Roe5y	9.3
ROIC	31.52
Roic5y	45.54

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	19.76%
Cagr3y	3.33%
Cagr5y	4.94%
Div CAGR3	-20.63%
Div CAGR5	-7.79%
EPS Growth	9.68
EPS Growth Q	6.67
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	-20.63
EPS Growth5 Y	-11.32
FCF Growth	35.69%
FCF Growth Q	26.26%
FCF Growth3 Y	-15.84%
FCF Growth5 Y	-8.55%
OCF Growth	28.99%
OCF Growth Q	23.86%
OCF Growth10 Y	-5.77%
OCF Growth3 Y	-18.31%
OCF Growth5 Y	-9.35%
Revenue Growth	-0.86x
Revenue Growth Q	-5.13x
Revenue Growth Years	0x
Revenue Growth3 Y	-8.94x
Revenue Growth5 Y	-1.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.28
Assets	CNY 921.4M
Cash	CNY 771.5M
Current Assets	CNY 808.5M
Current Liabilities	CNY 49.4M
Equity	CNY 864.4M
Liabilities	CNY 57M
Long Term Assets	CNY 112.9M
Long Term Liabilities	CNY 7.6M
Net Cash	CNY 771.5M
Net Cash By Market Cap	CNY 29.01
Net Cash Growth	5.65%
Net Debt EBITDA	CNY -10.93
Net Debt Equity	CNY -0.89
Net Debt FCF	CNY -10.12
Tangible Book Value	CNY 856.9M
Tangible Book Value Per Share	CNY 5.36
WACC	6.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	16.38
Inventory Turnover	4.04
Net Working Capital	CNY -12.4M
Quick ratio	15.8
Working Capital	CNY 759.1M
Working Capital Turnover	CNY 0.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.91%
Dividend Growth	-25%
Dividend Growth Years	0%
Dividend per share	CNY 0.3
Dividend Years	9
Dividend Yield	1.81%
Ex Div Date	2025-05-28
Last Dividend	CNY 0.3
Payout Frequency	Annual
Payout Ratio	85.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	19.74%
200-day SMA	16.12
3Y total return	10.34%
50-day SMA	15.76
50-day SMA vs 200-day SMA	50under200
5Y total return	27.27%
All Time High	66.5
All Time High Change	-75.01%
All Time High Date	2016-08-18
All Time Low	7.67
All Time Low Change	116.69%
All Time Low Date	2016-06-24
ATR	0.46
Beta	0.41
Beta1y	0.17
Beta2y	0.54
Ch YTD	11.54
High	16.69
High52	20.36
High52 Date	2025-08-01
High52ch	-18.37%
Low	16.23
Low52	13.71
Low52 Date	2025-06-23
Low52ch	21.23%
Ma50ch	5.49%
Price vs 200-day SMA	3.12%
RSI	62.8
RSI Monthly	55.86
RSI Weekly	55.96
Sharpe ratio	0.75x
Sortino ratio	1.33
Total Return	3.71%
Tr YTD	11.54
Tr1m	7.36%
Tr1w	1.78%
Tr3m	2.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 55.9M
Operating Income Growth	40.67
Operating Income Growth Q	49.85
Operating Income Growth3 Y	-24.15
Operating Income Growth5 Y	-12.01
Operating margin	21.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	74,800,100%
Shares Insiders	38.25%
Shares Institutions	1.37%
Shares Out	160,000,000
Shares Qo Q	8.39%
Shares Yo Y	-1.91%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 76.2M
Average Volume	3,069,109.65x
Bv Per Share	5.4
CAPEX	CNY -2.7M
Ch1m	7.36
Ch1w	1.78
Ch1y	17.29
Ch3m	2.15
Ch3y	1.65
Ch5y	9.49
Ch6m	2.72
Change	1.65%
Change From Open	1.53
Close	16.35
Days Gap	0.12
Depreciation Amortization	14,736,126
Dollar Volume	47,903,826
Earnings Date	2026-08-25
EBIT	CNY 55.9M
EBITDA	CNY 70.6M
EPS	CNY 0.35
F Score	5
FCF	CNY 76.2M
FCF EV Yield	4.04x
FCF Per Share	CNY 0.48
Financing CF	-48,000,000
Fiscal Year End	December
Founded	1,998
Graham Number	6.53019
Graham Upside	-60.71
Income Tax	CNY 9.7M
Investing CF	-169,660,334
Is Primary Listing	1
Last Earnings Date	2025-10-24
Last Report Date	2026-03-31
Last Split Date	2017-07-04
Last Split Type	Forward
Lynch Fair Value	CNY 1.75
Lynch Upside	-89.45
Ma150	15.9
Ma150ch	4.55%
Ma20	15.74
Ma20ch	5.56%
Net CF	-138,757,411
Next Earnings Date	2026-08-25
Open	16.37
P FCF Ratio	34.89
P OCF Ratio	33.7
Payment Date	2025-05-28
Position In Range	84.78
Ppne	89,549,333
Price Date	2026-05-08
Price EBITDA	CNY 37.67
Ptbv Ratio	3.1
Relative Volume	0.94x
Revenue	260,579,057x
Tax By Revenue	3.72x
Tax Rate	14.76%
Tr6m	2.72%
Volume	2,882,300
Z Score	28.67

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300519 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$0.30 annual per share

Payout ratio

+85.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-7.8%

0 consecutive years of growth

Total shareholder yield

+3.7%

Next ex-dividend date: 2025-05-28

Performance

SHE/300519 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300519?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.4%

Share of float held by funds and institutions

Insider ownership

+38.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.9%

Negative means the company is buying back shares.

Technical

SHE/300519 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.8

Neutral momentum band

Price vs 200-day MA

+3.1%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

0.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300519

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300519 stock rating?

she/300519 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300519 analysis?

The full report lives at /stocks/she/300519/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300519?

The latest report frames she/300519 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300519 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.